• The lack of a data safety monitoring board is "sub-optimal, " says Steven Joffe, a bioethicist and researcher at the Dana Farber Cancer Center.

    FORBES: Magazine Article

  • Dr. Mark Kieran, director of pediatric medical neuro-oncology at Boston Children's Hospital and Dana Farber Cancer Insititute, is the principal investigator of the study.

    CNN: Advances in kids' early aging disease

  • Dr. ERIC WEINER (Dana Farber Cancer Institute): And I think it really speaks to the underlying nature and behavior of hormone receptor positive breast cancer.

    NPR: Study: Drug Can Curb Breast Cancer Recurrence

  • Nor did it follow them for five years or more, according to Eric Winer, an oncologist at the Dana Farber Cancer Institute who led the study.

    FORBES: Searching For An Heir To Tamoxifen

  • Among them was Ken Anderson , director of the Jerome Lipper Multiple Myeloma Center at the Dana Farber Cancer Institute and a professor at Harvard Medical School.

    FORBES: The Man Behind Millennium's Cancer Drug

  • Under all current treatments, including bone marrow transplants, all patients relapse, notes Dr. Ken Anderson, director of the Jerome Lipper Multiple Myeloma Center at the Dana Farber Cancer Institute.

    FORBES: Magazine Article

  • Researchers may have to do many small trials of combinations of immune-boosting drugs until they find which combos work best on which patients, says Dana Farber Cancer Institute's Glenn Dranoff.

    FORBES: Magazine Article

  • Philip Kantoff, a urological oncologist at Harvard Medical School and the Dana Farber Cancer Institute, is conducting a big clinical trial that should firmly establish whether and how much Provenge helps patients.

    FORBES: Magazine Article

  • Dana-Farber's Mayer says he's encouraged that the results are similar in different kinds of tumors.

    FORBES: Magazine Article

  • Already, a coalition was forged between Adams and academics at the Dana-Farber Cancer Institute and the National Cancer Institute.

    FORBES: Magazine Article

  • Researchers at the Dana-Farber Cancer Institute in Boston took Celgene's improved version, Revlimid, and rushed it into myeloma trials.

    FORBES: Health

  • "This has profound implications, " says researcher Thomas Look of Boston's Dana-Farber Cancer Institute.

    FORBES: Cancer Killer

  • The current trial by George Demetri, a GIST expert at the Dana-Farber Cancer Institute, tested SU-11248 in patients who had failed Gleevec.

    FORBES: Pfizer Cancer Pill Proves Effective

  • Winer, director of the Breast Oncology Center at the Dana-Farber Cancer Institute.

    FORBES: Questions Swirl Around Avastin

  • "I keep telling them that they need to think more like a biotech, " says George Demetri , an oncologist at the Dana-Farber Cancer Institute.

    FORBES: Pfizer Takes Cancer By Storm

  • Demetri of the Dana-Farber Cancer Institute, who codesigned trials of AP23573 after big successes with other fast-tracked pills, such as Gleevec and Pfizer's Sutent.

    FORBES: Mission Improbable

  • Gary Gilliland, a hematologist at the Dana-Farber Cancer Institute, used a Web discussion board to recruit hundreds of patients willing to give him genetic samples.

    FORBES: Magazine Article

  • Dr. Eric Weiner of Dana-Farber Cancer Institute in Boston says it's really unusual for a drug to be so effective such a long time after diagnosis.

    NPR: Study: Drug Can Curb Breast Cancer Recurrence

  • Under the microscope "it looks like a small bomb went off in the nucleus, " says George Demetri, an oncologist at the Dana-Farber Cancer Institute in Boston.

    FORBES

  • This study, which was led by Paul Richardson at the Dana-Farber Institute, tested only the sickest patients suffering from a relatively rare cancer called multiple myeloma.

    FORBES: Millennium's Future

  • "I don't know anyone who offers women the option of doing nothing, " says Eric Winer, director of the breast cancer program at Dana-Farber Cancer Institute in Boston.

    WSJ: Can Breast Cancer Be Overtreated?

  • But the debilitating effects on a patient's sexuality are often ignored, said Sharon Bober, director of the sexual health program at the Dana-Farber Cancer Institute in Boston.

    CNN: Let's talk about sex ... and cancer

  • "Definitive studies to show it is better than Taxol have yet to be done, " says Eric Winer, a top breast cancer researcher at the Dana- Farber Cancer Institute.

    FORBES: Patrick Soon-Shiong and one of cancer's biggest riddles.

  • " Says Robert Mayer , director of the center for gastrointestinal oncology at the Dana-Farber Cancer Institute: "I think it's hard to be anything but enthusiastic about the results.

    FORBES: Magazine Article

  • "That's very impressive, " says Paul Richardson, a myeloma specialist at the Dana-Farber Cancer Institute who has worked on other Celgene-sponsored trials but did not participate in this Thalomid study.

    FORBES: Thalomid Fuels Celgene's Rise

  • "That is absolutely the case, " agrees Dr. Ann Partridge, clinical director of the Breast Oncology Center at the Dana-Farber Cancer Institute, who also does research on improving health care communication.

    CNN: Cancer survivor's own fat gives her new breasts

  • "The two different types have fairly dramatically different clinical behaviors, " said Matthew Kulke, director of the carcinoid and pancreatic neuroendocrine tumor program at the Harvard-affiliated Dana-Farber Cancer Institute in Boston.

    WSJ: Apple Co-Founder Steve Jobs's Rare Disease Ran Predictable Course

  • Slovenia, and a radiation oncologist at Dana-Farber Cancer Institute.

    FORBES: When 450,000 People Can't be Wrong

  • He splits his time with the Dana-Farber Cancer Institute.

    FORBES: A Cancer Patient's Quest Hits DNA Pay Dirt

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定